Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial - Kvistad, C E; Næss, H; Helleberg, B H (Lancet Neurol, 2022)